Naatson Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 30-07-2024
- Paid Up Capital ₹ 1.94 M
as on 30-07-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 30-07-2024
- Revenue -6.48%
(FY 2023)
- Profit -6.67%
(FY 2023)
- Ebitda 17.50%
(FY 2023)
- Net Worth 4.12%
(FY 2023)
- Total Assets 12.24%
(FY 2023)
About Naatson Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.94 M.
The company currently has active open charges totaling ₹5.00 M.
Jaykishan Agrawal, Ashish Agrawal, and Suman Agrawal serve as directors at the Company.
- CIN/LLPIN
U85110TN1999PTC042717
- Company No.
042717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai - 600 087., Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Naatson Healthcare Private Limited offer?
Naatson Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Mineral Supplement, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Common Disease Medicines, Oral Care Products, Pharmaceutical Syrup.
Who are the key members and board of directors at Naatson Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaykishan Agrawal  | Managing Director | 25-Jun-1999 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Agrawal | Director | 05-Aug-2011 | Current |
| Suman Agrawal | Director | 09-May-2022 | Current |
Financial Performance of Naatson Healthcare.
Naatson Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.48% decrease. The company also saw a slight decrease in profitability, with a 6.67% decrease in profit. The company's net worth moved up by a moderate rise of 4.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Naatson Healthcare?
In 2023, Naatson Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Aug 2020 | ₹5.00 M | Open |
How Many Employees Work at Naatson Healthcare?
Unlock and access historical data on people associated with Naatson Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naatson Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naatson Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
